Enguerran Mouly

Paris, 75012, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Tet2 deficiency promotes IgG1+ B-cell expansion and differentiation blockade through deregulation of the Nfkbia-c-Rel axis.

Tet2 deficiency promotes IgG1+ B-cell expansion and differentiation blockade through deregulation of the Nfkbia-c-Rel axis.

Journal: HemaSphere
Published: August 09, 2025

Single-cell transcriptomic profiling of the mouse cochlea: An atlas for targeted therapies.

Single-cell transcriptomic profiling of the mouse cochlea: An atlas for targeted therapies.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 20, 2023

Molecular pathogenesis of progression to myeloid leukemia from TET-insufficient status.

Molecular pathogenesis of progression to myeloid leukemia from TET-insufficient status.

Journal: Blood advances
Published: December 09, 2019

Nfkbie-deficiency leads to increased susceptibility to develop B-cell lymphoproliferative disorders in aged mice.

Nfkbie-deficiency leads to increased susceptibility to develop B-cell lymphoproliferative disorders in aged mice.

Journal: Blood cancer journal
Published: November 22, 2019

TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis.

TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis.

Journal: Cancer discovery
Published: June 13, 2018

B-cell tumor development in Tet2-deficient mice.

B-cell tumor development in Tet2-deficient mice.

Journal: Blood advances
Published: November 12, 2017

DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice.

DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice.

Journal: Leukemia
Published: September 14, 2015

TET proteins and the control of cytosine demethylation in cancer.

TET proteins and the control of cytosine demethylation in cancer.

Journal: Genome medicine
Published: January 30, 2015

Acquired initiating mutations in early hematopoietic cells of CLL patients.

Acquired initiating mutations in early hematopoietic cells of CLL patients.

Journal: Cancer discovery
Published: June 13, 2014

A prospective study of bone marrow hematopoietic and mesenchymal stem cells in type 1 Gaucher disease patients.

A prospective study of bone marrow hematopoietic and mesenchymal stem cells in type 1 Gaucher disease patients.

Journal: PloS one
Published: November 21, 2012

The Ets-1 transcription factor is required for Stat1-mediated T-bet expression and IgG2a class switching in mouse B cells.

The Ets-1 transcription factor is required for Stat1-mediated T-bet expression and IgG2a class switching in mouse B cells.

Journal: Blood
Published: March 23, 2012

The human immunodeficiency virus-1 protease inhibitor nelfinavir impairs proteasome activity and inhibits the proliferation of multiple myeloma cells in vitro and in vivo.

The human immunodeficiency virus-1 protease inhibitor nelfinavir impairs proteasome activity and inhibits the proliferation of multiple myeloma cells in vitro and in vivo.

Journal: Haematologica
Published: January 25, 2012
Showing 1-12 of 13

Last Updated: 09/26/2026